Related Experiment Videos

Prognostic significance of myelodysplasia-related changes according to the WHO classification among

Raynier Devillier¹, Véronique Gelsi-Boyer, Anne Murati

¹Hematology Department, Institut Paoli Calmettes, Marseille, France; Aix-Marseille University, Marseille, France.

American Journal of Hematology

|September 16, 2014

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Initiating transformative medical practices to address environmental challenges - proceedings of "Santé en 2050", the French national conference on healthcare adaptation.

Reviews on environmental health·2026

Limited Prognostic Value of ELN Classification and Relevance of Molecular Ontogeny in Acute Myeloid Leukemia post Myeloproliferative Neoplasms: A Retrospective Multicenter Study.

Acta haematologica·2026

Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial.

The Lancet. Haematology·2026

Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results.

Leukemia·2026

Improving transparency and empowerment for cancer patients by accessing their full online personal medical records.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025

Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMC.

Leukemia research·2025

See all related articles